CeNeRx BioPharma Announces Positive Phase I Results In First Human Trial Of Third Generation RIMA Antidepressant February 15, 2009
CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today announced top-line results from a Phase I clinical trial of Tyrima(TM), its lead candidate for the treatment of depression and anxiety. In this study, Tyrima was safe and well tolerated. Tyrima is a member of [...]
